uman milk banks provide an alternative to formula feeds for preterm babies when the mother's breast milk is unavailable. The first human milk bank in the United Kingdom opened at Queen Charlotte's Hospital, London in 1939. The emergence of the human immunodeficiency virus resulted in the disappearance of many human milk banks in the 1980s. However, there are currently at least 16 operating in the UK, with others being developed. Most are attached to neonatal units (the one in Northern Ireland is based at a health centre and managed by a health visitor). The UK Association of Milk Banks, a registered charity, provides guidelines for their operation, and the third edition these guidelines were updated using a more rigorous evidence based methodology.
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There are few studies specifically using pasteurised donor breast milk in preterm infants, and therefore much of the evidence has to be extrapolated from studies including babies fed at the breast and those fed their mother's own unpasteurised breast milk. The guidelines discuss what is known about the consequences of pasteurisation of breast milk for feeding to unrelated preterm infants. They cover the selection of donors, and the collection, preparation, storage and treatment of donor breast milk. They include information leaflets both for potential donors (with instructions) and mothers of recipient babies. There are good practice points on record keeping, staffing a milk bank, and archiving donor samples in case of a subsequent problem. They do not cover the management of mothers' milk fed to their own babies, nor the indications for using donor breast milk. 
MAIN POINTS (RECOMMENDATIONS GRADE D UNLESS STATED)

COMMENTARY
The guidelines provide comprehensive advice to those operating human milk banks, supported by a detailed review of the evidence based on a thorough literature search. The recommendations should be used for quality assurance of the operation of milk banks. Those contemplating setting up a milk bank will find a fully referenced review of the benefits of feeding pasteurised donor milk to preterm infants. The guidelines demonstrate the paucity of direct research evidence about the use of pasteurised donor milk in preterm infants. A number of studies have demonstrated short and long term benefits from the use of breast milk over preterm formula feeds. The references cited provide direct evidence of benefit in preterm infants from pasteurised donor milk for the prevention of necrotising enterocolitis and its association with lower blood pressure in adolescence. These are the parts of the statement about the benefits for which a grade B is appropriate.
Another major consideration is the risk of transmitting serious infections, especially HIV. Whereas there is no direct evidence of risk of transmission of HIV from pasteurised breast milk, the guidelines are necessarily based on the assumption of risk, and include criteria for excluding potential donors, and a requirement for potential donors to be serologically tested.
The guidelines list 16 neonatal units in the UK that consider the use of pasteurised donor milk to be sufficiently beneficial to justify maintaining a milk bank. Other units considering setting up their own milk banks will find the guidelines valuable in weighing up the evidence of benefit against the costs and potential infection risks.
The guidelines are available via www.ukamb.org (priced at £20)
Recommendation grades and levels of evidence
Grade Evidence A At least one high quality meta-analysis, systematic review of RCTs or RCT with a very low risk of bias and directly applicable to the target population, or a body of evidence principally from well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias, directly applicable to the target population and demonstrating overall consistency of results B A body of evidence from high quality systematic reviews of case-control or cohort studies or high quality casecontrol or cohort studies with a very low risk of confounding, bias, or chance and a high probability that the relation is causal, directly applicable to the target population, and demonstrating overall consistency of results; or extrapolated evidence from high quality metaanalyses, systematic reviews of RCTs, or RCTs with a very low risk of bias C A body of evidence from well conducted case-control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relation is causal, directly applicable to the target population and demonstrating overall consistency of results; or extrapolated evidence from high quality systematic reviews of case-control or cohort studies or high quality case-control or cohort studies with a very low risk of confounding, bias, or chance and a high probability that the relationship is causal D Evidence from non-analytic studies, eg, case reports, case series; evidence from expert opinion; or extrapolated evidence from case control or cohort studies with more than a very low risk of confounding, bias, or chance, and less than a high probability that the relation is causal ep28 GUIDELINE REVIEW www.archdischild.com
